A small device combining technology and medicine may well make life easier for many people with Type 2 diabetes. Recently published in le New England Journal of Medicine, A North American study highlights the benefits ofan automated insulin system.
This device combines an insulin pump and a sensor fixed on the skin. The sensor measures continuously sugar levels In the blood and sends the data to the pump, which automatically adjusts the doses, both the day and the night. This real -time regulation makes it possible to limit excess sugar (hyperglycemia) and too low falls (hypoglycemia).
For 13 weeks, 319 adults under insulin participated in the test. Two thirds used this automated system, while the others continued their usual treatment (injections or un automatized pump), all being followed by a blood sugar sensor.
The results are clear:
- Greater drop in glycated hemoglobin (–0.9 point against –0.3 point with conventional methods).
- On average, an additional 3 hours 30 per day spent in the ideal sugar beach (70 to 180 mg/dl).
- Marked reduction in hyperglycemia episodes, with an effect noted in the first week.
In terms of securityno serious incident has been reported. A single case of severe hypoglycemia occurred in the group using the device, without technical problem. Users have also slightly reduced their daily dose of insulin, while recording weight gain average 2,4 kg.
Researchers point out that this technology, already widespread in people with type 1 diabetes, could also improve life Type 2 patients Who use insulin, by providing them with better sugar control and more fluid management of their treatment.